Table 2.

Hypoglycemia sampling results in patients with CHI or IKH.

	CHI	IKH	p-value
P-glucose mmol/L, median (range)	2.6 (0.6–3.1); n=61	2.8 (2.3–3.1); n=15	0.0150
P-insulin pmol/L, median (range)	76.5 (17–644.3); n=61	1.5 (1.5–7.7); n=15	<0.0001
P-proinsulin pmol/L, median (range)	16 (3–200); n=58	1.5 (1.5–7)*; n=13	<0.0001
P-C-peptide pmol/L, median (range)	860 (225–5154); n=60	76 (32–109); n=15	<0.0001
Fast duration hours, median (range)	0.5 (0–10); n=42	12.5 (6–18); n=10	<0.0001
Glucose demand mg/kg/min., median (range)	11.6 (1–23.7); n=39	0	N/A
Concomitant medical treatment, no (%)	4** (6.4)	2*** (13.3)	N/A

*One outlier with p-proinsulin of 189 pmol/L not included.

**All four on octreotide treatment (patients included as p-insulin was >55 pmol/L).

***Both had inhalation corticosteroids in non-systemic dosage.